# ADEQUACY ASSESSMENT - EXECUTIVE SUMMARY

**Date**: 2025-10-30
**Status**: Phase 5 Complete
**Analyst**: Modeling Workflow Assessor

---

## FINAL DECISION: CONTINUE

**Implement Experiment 3 (AR(2) structure) before declaring adequacy**

**Confidence**: HIGH (85%)

---

## Decision in One Sentence

"Experiment 2 (AR(1) Log-Normal) is substantially better than baseline and fit for current use, but has a well-diagnosed, fixable limitation (residual ACF = 0.549) with a clear improvement path (AR(2)) at low cost—one more experiment completes the logical arc before declaring adequacy."

---

## Quick Decision Matrix

| Criterion | Status | Implications |
|-----------|--------|--------------|
| **Minimum experiments completed** | ✅ 2/2 | Met requirement |
| **At least one model accepted** | ✅ Exp 2 | Can proceed to Phase 6 |
| **Clear improvement achieved** | ✅ +177 ELPD | Major progress |
| **Falsification criteria met** | ⚠️ 1/6 | AR(1) insufficient |
| **Obvious next step exists** | ✅ AR(2) | Low cost, clear path |
| **Scientific questions answerable** | ✅ Yes | But interpretation incomplete |
| **Computational feasibility** | ✅ Perfect | No barriers |
| **Recommendations made** | ✅ AR(2) | Should test before concluding |

**Conclusion**: Can stop (minimum requirements met) but should continue (clear improvement path exists at low cost).

---

## Why CONTINUE (Not ADEQUATE or STOP)

### The Core Argument

**Experiment 2 tells us exactly what's missing**: The residual ACF pattern (elevated at lags 1-3, then rapid decay) is a classic signature of missing AR(2) structure. We successfully captured lag-1 dependence (phi = 0.847), but higher-order temporal structure remains.

**One more experiment completes the story**:
- If AR(2) succeeds (residual ACF < 0.3): Accept as final model, proceed to Phase 6
- If AR(2) fails (ΔELPD < 10): Accept AR(1) with evidence that AR(2) wasn't needed
- Either outcome strengthens our conclusions

### 8 Reasons to Continue

1. **Pre-specified criterion met**: Residual ACF > 0.3 was set as falsification trigger before seeing results
2. **Clear improvement path**: AR(2) structure directly addresses diagnosed limitation
3. **Low marginal cost**: 1-2 days, reuse 95% of infrastructure
4. **Moderate expected benefit**: ΔELPD ~ 20-50 points likely
5. **Recent improvement substantial**: +177 ELPD (not in diminishing returns phase)
6. **Scientific rigor**: Test recommended improvement before claiming adequacy
7. **Haven't explored obvious alternative**: AR(2) is natural next step
8. **Scientific interpretation changes**: 1-period vs 2-period memory has different mechanistic implications

### 4 Reasons NOT to Declare Adequate Now

1. **Violates own criteria**: We set ACF < 0.3 threshold, model shows 0.549
2. **Premature closure**: Stopping when the model itself flags what's missing
3. **Incomplete exploration**: AR(2) is obvious and untested
4. **Weaker credibility**: Reviewers will ask "Did you try AR(2)?" (answer would be no)

### 4 Reasons NOT to Stop (Different Approach)

1. **No fundamental failure**: AR(1) succeeded conditionally, not failed repeatedly
2. **No data quality issues**: Data are high-quality, sufficient for purpose
3. **No computational barriers**: Perfect convergence, 2-minute runtime
4. **Not in diminishing returns**: Last improvement was massive (+177 ELPD)

---

## The Numbers

### Model Performance

| Metric | Experiment 1 (Rejected) | Experiment 2 (Conditional) | Improvement |
|--------|-------------------------|---------------------------|-------------|
| ELPD_LOO | -170.96 ± 5.60 | +6.13 ± 4.32 | **+177.1 ± 7.5** |
| MAE | 16.53 | 14.53 | **-12%** |
| RMSE | 26.48 | 20.87 | **-21%** |
| 90% Coverage | 97.5% (over) | 90.0% (perfect) | **Nominal** |
| Residual ACF | 0.596 (failed) | 0.549 (borderline) | **-8%** |
| R-hat | 1.000 | 1.000 | Tie |
| ESS | >1900 | >5000 | **+160%** |
| Stacking Weight | ≈0.000 | 1.000 | **Winner** |

**ΔELPD Significance**: 177.1 / 7.5 = **23.7 standard errors** (overwhelming)

### Falsification Criteria

**Experiment 1**: Met 2 of 4 criteria → REJECTED
- ✗ Residual ACF > 0.5 (observed: 0.596)
- ✗ PPC shows systematic bias (p < 0.001)

**Experiment 2**: Met 1 of 6 criteria → CONDITIONAL ACCEPT
- ✗ Residual ACF > 0.3 (observed: 0.549) ← This one matters
- ✓ Convergence excellent (R-hat = 1.00, ESS > 5000)
- ✓ Calibration perfect (90.0% coverage)
- ✓ LOO reliable (90% Pareto-k < 0.5)
- ✓ PPC passes (all 9 tests, p > 0.5)
- ✓ Better than Exp 1 (ΔELPD = +177)

**Interpretation**: Only 1 of 6 criteria met, but that 1 criterion is diagnostic of specific, addressable issue.

---

## Risk-Benefit Analysis

### Benefits of Continuing (AR(2))

| Benefit | Probability | Value |
|---------|-------------|-------|
| Reduce residual ACF below 0.3 | 60% | HIGH (achieve adequacy) |
| Moderate improvement (ΔELPD 10-50) | 70% | MEDIUM (strengthens model) |
| Validate AR(1) adequate (minimal gain) | 20% | LOW (but informative) |
| Discover new insight | 15% | MEDIUM (scientific value) |

**Expected outcome**: 60-70% chance of meaningful improvement, 20% chance of validating AR(1), 10% chance of surprises.

### Costs of Continuing

| Cost | Magnitude | Mitigation |
|------|-----------|------------|
| Time investment | 1-2 days | Acceptable for publication-quality |
| Complexity increase | +1 parameter | Stationarity constraint well-understood |
| Convergence risk | Low (<5%) | Exp 2 converged perfectly, AR(2) similar |
| Diminishing returns risk | Moderate (20%) | If occurs, accept AR(1) with evidence |

**Net assessment**: Benefits substantially outweigh costs.

### Risks of Stopping Now

| Risk | Probability | Consequence |
|------|-------------|-------------|
| Miss 20-50 ELPD improvement | 60% | Suboptimal model published |
| Reviewer criticism | 80% | "Why not AR(2)?" is obvious question |
| Violate pre-specified criteria | 100% | Loss of methodological credibility |
| Incomplete scientific understanding | 50% | 1-period vs 2-period memory unresolved |

**Net assessment**: Stopping now has higher regret potential than continuing.

---

## Stopping Rule for Experiment 3

After AR(2) is tested, make final determination using these criteria:

### ACCEPT AR(2) if:
- Residual ACF < 0.3, OR
- 0.2 < ACF < 0.3 AND ΔELPD vs AR(1) > 10

### ACCEPT AR(1) if:
- AR(2) shows minimal improvement (ΔELPD < 10), OR
- AR(2) has convergence issues, OR
- AR(2) residual ACF similar to AR(1) (difference < 0.1)

### RECONSIDER APPROACH if:
- AR(2) fails to converge across multiple attempts, AND
- AR(1) residual ACF still > 0.5, OR
- AR(2) reveals unexpected fundamental issue

**Expected outcome**: Accept AR(2) or AR(1) with evidence. Proceed to Phase 6.

**No Experiment 4 planned** unless AR(2) reveals completely unexpected issue (probability < 5%).

---

## What "CONDITIONAL ACCEPT" Means

Experiment 2 (AR(1)) is:

### ✅ Good Enough For:
- Current exploratory analysis
- Preliminary scientific inference
- Comparison to baseline (Experiment 1)
- Trend estimation with caveats
- Short-term forecasting (1-3 periods)
- Demonstrating value of temporal structure

### ⚠️ Use With Caution For:
- Hypothesis testing (SEs may be underestimated)
- Longer-term forecasting (4+ periods)
- Claims about temporal process (incomplete specification)
- Residual-based diagnostics (not fully independent)

### ❌ Not Good Enough For:
- Final publication model (AR(2) should be tested first)
- Claims of adequate temporal specification (known limitation)
- High-stakes decision-making without caveats
- Ignoring pre-specified falsification criterion

**Analogy**: It's like a "revise and resubmit" decision—the work is valuable and substantially correct, but needs one more refinement before final acceptance.

---

## Timeline and Resources

### Time Investment So Far
- Experiment 1: 1 day (design, implement, validate, critique) → REJECTED
- Experiment 2: 1.5 days (design, implement, validate, critique) → CONDITIONAL
- Model Comparison: 0.5 days (LOO-CV, visualizations, report)
- Adequacy Assessment: 0.5 days (this document)
- **Total**: 3.5 days

### Experiment 3 Estimate
- Design: 2-4 hours (specification, priors)
- Implementation: 4-6 hours (code, debugging)
- Validation: 4-6 hours (inference, PPC, diagnostics)
- Comparison: 2-4 hours (LOO-CV vs AR(1))
- Assessment: 1-2 hours (final determination)
- **Total**: 1-2 days

### Project Total
- **Current**: 3.5 days
- **With Exp 3**: 4.5-5.5 days
- **Reasonable?**: YES for publication-quality Bayesian analysis

### Computational Resources
- **Current**: 1-3 minutes per model on standard hardware
- **AR(2) expected**: 2-5 minutes (trivial increase)
- **Storage**: 2-15 MB per experiment (negligible)
- **No special hardware required**: CPU-only, no GPU needed

---

## Alternative Decisions Considered

### Option A: ADEQUATE (Unconditional)
**Argument**: Experiment 2 is overwhelmingly better than baseline, only 1 of 6 falsification criteria met, predictions well-calibrated.

**Probability correct**: 30%

**Why not chosen**: Ignores legitimate limitation, doesn't plan for improvement, violates pre-specified criteria, premature closure.

### Option B: STOP (Different Approach)
**Argument**: Two experiments completed thoroughly, massive improvement achieved, time to report findings.

**Probability correct**: 5%

**Why not chosen**: No fundamental barriers, not in diminishing returns, obvious next step exists, would waste opportunity.

### Option C: CONTINUE (Chosen)
**Argument**: Clear improvement path, low cost, moderate benefit, honors pre-specified criteria, completes logical arc.

**Probability correct**: 85%

**Risks**: Might show minimal improvement (acceptable—we'd learn that), small time investment.

---

## Key Insights from Modeling Journey

### What Worked
1. **Falsification criteria**: Pre-specified thresholds prevented rationalization
2. **Iterative refinement**: Each model revealed what next model should address
3. **Comprehensive validation**: 4-phase workflow caught issues early
4. **Clear comparisons**: LOO-CV provided decisive model selection
5. **Honest assessment**: Conditional acceptance acknowledges limitations while recognizing progress

### What We Learned
1. **Independence assumption inadequate**: Cost = 177 ELPD points
2. **AR(1) structure necessary**: phi = 0.847 highly significant
3. **Higher-order structure exists**: Residual ACF indicates lag-2 dependence
4. **Regime structure validated**: Three distinct variance regimes identified
5. **Exponential growth with momentum**: Substantive scientific interpretation

### What Remains Unknown
1. **Is AR(2) sufficient?**: Or do we need AR(3)? (likely AR(2) adequate)
2. **Regime boundary uncertainty**: Fixed from EDA, not estimated (acceptable limitation)
3. **Long-term forecast accuracy**: Short-term validated, long-term uncertain
4. **Generalization**: How well does model predict future data?

**These unknowns are acceptable**—no model is perfect, but AR(2) test resolves the primary uncertainty.

---

## Meta-Reflection

### Are We Over-Engineering?

**NO**. Evidence:
- Each refinement addressed specific, major limitation
- Improvements substantial (177 ELPD), not marginal
- AR structure is standard for time series, not exotic
- Pre-specified criteria guide decisions, not ad-hoc tuning
- Use case (scientific inference + forecasting) requires appropriate modeling

**Analogy**: Fitting quadratic when linear fails is appropriate refinement, not over-engineering.

### Are We Chasing Perfection?

**NO**. We're addressing a specific, diagnosed limitation (residual ACF) with a clear solution (AR(2)) at low cost. If AR(2) doesn't substantially improve, we accept AR(1). This is pragmatic, not perfectionist.

**Perfection would be**: "Let's try AR(3), AR(4), ARMA, state-space models, GPs, neural ODEs..."

**What we're doing**: "Let's test the one obvious next step (AR(2)), then decide."

### Is This Good Science?

**YES**. Characteristics of good science:
- Pre-specified hypotheses and falsification criteria ✓
- Iterative refinement based on evidence ✓
- Transparent reporting of limitations ✓
- Comparative evaluation with uncertainty ✓
- Stopping rule to prevent endless iteration ✓
- Balance of rigor and pragmatism ✓

---

## For the Record

### What This Decision DOES Mean
- The current model (Exp 2) is useful and substantially better than baseline
- One more refinement is justified before declaring adequacy
- Scientific process is working as designed (iterative, evidence-based)
- Partial success should be recognized and built upon

### What This Decision DOES NOT Mean
- The current model is useless (it's conditionally accepted)
- We're chasing perfection (we have a stopping rule)
- Falsification criteria should be ignored (we're honoring them)
- We'll iterate indefinitely (Exp 3 is the planned last experiment)

### In Plain English

"We've made excellent progress. The current model is good, but it tells us exactly what's missing (lag-2 dependence). Testing that will take 1-2 days and either improve the model or validate that what we have is adequate. That's a worthwhile investment before concluding the analysis."

---

## Next Steps

1. **Design Experiment 3**: AR(2) Log-Normal specification
2. **Implement**: Reuse Experiment 2 infrastructure, add lag-2 term
3. **Validate**: Same 4-phase workflow (prior PPC, optional SBC, inference, posterior PPC)
4. **Compare**: LOO-CV of AR(1) vs AR(2)
5. **Assess**: Final adequacy determination using stopping rule
6. **Report**: Proceed to Phase 6 with best model

**Timeline**: Begin Experiment 3 immediately, target completion in 1-2 days.

---

## Confidence Assessment

**Overall Decision Confidence**: HIGH (85%)

**Breakdown**:
- That Experiment 2 is better than Experiment 1: 99.9% (overwhelming evidence)
- That residual ACF indicates real limitation: 90% (clear diagnostic pattern)
- That AR(2) will improve over AR(1): 60-70% (likely but not certain)
- That AR(2) is worth testing: 95% (low cost, clear benefit)
- That this is the right decision: 85% (weighing all factors)

**Sources of Remaining Uncertainty (15%)**:
- AR(2) might show minimal improvement (10%) → Would validate AR(1)
- AR(2) might have convergence issues (3%) → Would accept AR(1) as best feasible
- Residual ACF might be spurious (2%) → AR(2) test would reveal this

**None of these undermine the decision**—testing AR(2) resolves the uncertainty either way.

---

## Conclusion

**DECISION**: **CONTINUE** to Experiment 3 (AR(2) structure)

**CONFIDENCE**: HIGH (85%)

**NEXT MILESTONE**: Final adequacy assessment after Experiment 3 completion

**EXPECTED TIMELINE**: 1-2 days to next decision point

**REPORT LOCATION**: `/workspace/experiments/adequacy_assessment.md` (full details)

---

**Assessment Date**: 2025-10-30
**Analyst**: Modeling Workflow Assessor
**Status**: FINAL - Proceed to Experiment 3 Design
